Biomarkers as a guide to therapy in heart failure patients
Wednesday, January 28, 2009 - 16:21
in Health & Medicine
There has been much interest in the biomarker known as N-terminal brain natriuretic peptide (BNP) as a precise guide for the diagnosis, prognosis and treatment of heart failure. Earlier studies showed that this peptide released by the heart muscle in response to stress lowers blood pressure and has diuretic properties, with levels increased in patients with heart failure. Hence the interest in this peptide as a marker for the exclusion or presence and severity of heart failure...
Read the whole article on Science Centric
More from Science Centric
Related
- Using heart biomarker levels to guide therapy does not improve outcomes for heart failure patientsTue, 27 Jan 2009, 16:22:25 EST
- Biomarkers as a guide to therapy in heart failure patientsTue, 27 Jan 2009, 16:22:18 EST
- Improved predictive value of biomarkers in HF makes earlier diagnosis and better management possibleMon, 30 Mar 2009, 9:30:36 EDT
- Novel biomarkers in heart failureSat, 30 May 2009, 9:21:43 EDT
- Implantable monitor may help in managing diastolic heart failureThu, 11 Dec 2008, 11:57:56 EST